NYSE:ZBH
Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 1 opinions in the last 12 months.
Zimmer Biomet Holdings Inc. (ZBH-N) experienced a notable drop of over 3% in its stock price despite reporting what many considered a strong quarter. The company's outlook has remained consistent; however, they have lowered their sales guidance primarily due to adverse currency fluctuations. This decision has impacted investor sentiment, contributing to a decline of 11% in the stock's performance this year. Many analysts express concern that the reiteration of guidance without providing new, positive catalysts might have led to disappointment among shareholders. As the company navigates these challenges, it remains to be seen how they will adapt to maintain growth and investor confidence moving forward.
Thinks it is time to look at certain parts of healthcare. The situation is a little muddied, because we are faced with changes to the Affordable Care Act, and are not sure what form they are going to take and who it is going to affect. This company is a maker of joints, artificial hips, etc. There is some risk of competition and commoditization of these devices. He would probably look for another area in the healthcare arena. Some of the larger insurers are very interesting.
They reported earnings that met expectations but guidance was tepid. It spooked the market with a suggestion of slower growth. Anything hinting at slower growth in the healthcare space has this effect. Short term investors should stay out of healthcare. 3-5 year horizon investors will find this a great company to hold.
Zimmer Biomet Holdings Inc. is a American stock, trading under the symbol ZBH-N on the New York Stock Exchange (ZBH). It is usually referred to as NYSE:ZBH or ZBH-N
In the last year, 2 stock analysts published opinions about ZBH-N. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Zimmer Biomet Holdings Inc..
Zimmer Biomet Holdings Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Zimmer Biomet Holdings Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Zimmer Biomet Holdings Inc. In the last year. It is a trending stock that is worth watching.
On 2025-08-01, Zimmer Biomet Holdings Inc. (ZBH-N) stock closed at a price of $90.62.
ZBH will buy Orthopedic Robots, a deal he likes because the robotic surgery business is one of the most interesting corners of healthcare.